10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial
Titel:
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial
Auteur:
Lübbert, Michael Wijermans, Pierre W Kicinski, Michal Chantepie, Sylvain Van der Velden, Walter J F M Noppeney, Richard Griškevičius, Laimonas Neubauer, Andreas Crysandt, Martina Vrhovac, Radovan Luppi, Mario Fuhrmann, Stephan Audisio, Ernesta Candoni, Anna Legrand, Olivier Foà, Robin Gaidano, Gianluca van Lammeren-Venema, Danielle Posthuma, Eduardus F M Hoogendoorn, Mels Giraut, Anne Stevens-Kroef, Marian Jansen, Joop H de Graaf, Aniek O Efficace, Fabio Ammatuna, Emanuele Vilque, Jean-Pierre Wäsch, Ralph Becker, Heiko Blijlevens, Nicole Dührsen, Ulrich Baron, Frédéric Suciu, Stefan Amadori, Sergio Venditti, Adriano Huls, Gerwin